Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

ASPO Report

Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts

David E. Nelson, Jessica Faupel-Badger, Siobhan Phillips, Britni Belcher, Shine Chang, David B. Abrams, Barnett S. Kramer, Mary C. White, Michael O'Malley, Arti P. Varanasi, Carol J. Fabian, Jonathan S. Wiest, Graham A. Colditz, Kara Hall, Peter G. Shields and Jeffrey N. Weitzel
David E. Nelson
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Faupel-Badger
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siobhan Phillips
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Britni Belcher
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shine Chang
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David B. Abrams
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barnett S. Kramer
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary C. White
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael O'Malley
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arti P. Varanasi
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol J. Fabian
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan S. Wiest
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham A. Colditz
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kara Hall
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter G. Shields
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey N. Weitzel
1National Cancer Institute, Bethesda; 2Advancing Synergy, LLC, Baltimore, Maryland; 3University of Texas MD Anderson Cancer Center, Houston, Texas; 4Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, District of Columbia; 5Centers for Disease Control and Prevention, Atlanta, Georgia; 6University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina; 7University of Kansas Medical Center, Kansas City, Kansas; 8Washington University School of Medicine, St. Louis, Missouri; 9The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; and 10City of Hope, Duarte, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-1209 Published April 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Cancer prevention postdoctoral fellowships have existed since the 1970s. The National Cancer Institute facilitated a meeting by a panel of experts in April 2013 to consider four important topics for future directions for cancer prevention postdoctoral training programs: (i) future research needs; (ii) underrepresented disciplines; (iii) curriculum; and (iv) career preparation. Panelists proffered several areas needing more research or emphasis, ranging from computational science to culture. Health care providers, along with persons from nontraditional disciplines in scientific training programs such as engineers and lawyers, were among those recognized as being underrepresented in training programs. Curriculum suggestions were that fellows receive training in topics such as leadership and human relations, in addition to learning the principles of epidemiology, cancer biologic mechanisms, and behavioral science. For career preparation, there was a clear recognition of the diversity of employment options available besides academic positions, and that program leaders should do more to help fellows identify and prepare for different career paths. The major topics and strategies covered at this meeting can help form the basis for cancer prevention training program leaders to consider modifications or new directions, and keep them updated with the changing scientific and employment climate for doctoral degree recipients and postdoctoral fellows. Cancer Epidemiol Biomarkers Prev; 23(4); 679–83. ©2014 AACR.

Introduction

Formal funding of postdoctoral training programs in cancer prevention by the National Cancer Institute (NCI) in the United States began in the 1970s. As of May 2013, there were 30 postdoctoral cancer prevention and control fellowship programs supported by NCI grants*, as well as fellows supported through other means. Most programs support fellows for 2 to 4 years and are designed to train scientists for research careers in academic institutions. Although no standardized curriculum exists, most cancer prevention postdoctoral fellowships rely primarily on one-to-one mentoring, supplemented with lectures and other didactic training experiences.

Given changes occurring in science and technology, such as mapping of the genome and communication technology, and among the general population about economics and demographics (e.g., more limited government funding of science, aging of the U.S. population), this is an opportune time to consider where cancer prevention training fits in the larger picture of health workforce training. The NCI convened a group of 14 experts from academic institutions, government, and the private sector in Bethesda, MD to discuss future directions for postdoctoral training in cancer prevention in April 2013. The major topics addressed were: (i) future research needs; (ii) underrepresented disciplines; (iii) curriculum; and (iv) career preparation. This article summarizes ideas and strategies for cancer prevention training programs generated from group discussions at this meeting.

Future Research Needs

The panel first made suggestions about what they considered to be important cancer prevention research needs in the foreseeable future (1, 2). Panelists proffered several broad and specific areas needing more research or emphasis. These included computational science (e.g., statistics, mathematics, and informatics), behavioral science, communication, economics, and policy. Also suggested were health services research, the gene–environment interaction, genomics and other types of “omics,” dissemination and implementation (including innovation, sustainable science, and implementation in low resource settings; refs. 3, 4), transdisciplinary team science (5–7), evaluation, and systems science (7, 8). Finally, there was support for increased prevention research in global health, cancer or health disparities, and lifestyle risk factors (e.g., tobacco, diet, and physical activity).

Several participants stressed the importance of new, or newly adapted, research designs and methodologies. Examples included mathematical modeling (e.g., network analysis of social or behavioral factors, N-of-1 designs, and improved understanding of signal-to-noise ratios) and moving beyond single risk factor studies (9). Other specific ideas included assessing and interpreting scientific evidence, the challenge of reproducibility of scientific findings, refining evaluation of early detection methods (e.g., biomarkers), use and understanding of large and diverse (“big”) data sources, conducting more rapid and responsive research studies (10), communicating risk and uncertainty to lay audiences, and examining multilevel influences, such as the role of culture on normative population behaviors (7).

Broadening and Expanding Disciplines Involved in Cancer Prevention Research

Two long-standing challenges to the field are the absence of a widely accepted definition of cancer prevention and clearly defined career paths (1, 11). Cancer prevention covers topics that range from subcellular mechanisms to international health policies. Across the academic, government, and private sectors, there are few officially recognized departments, or other organizational units, devoted solely to cancer prevention.

Cancer prevention is multidisciplinary and many people may not identify or consider themselves cancer prevention scientists, although the intent of their activities may be to prevent or lower the incidence of cancer or other chronic diseases. Another challenge is that potentially interested individuals from some health science disciplines (e.g., physicians), or disciplines outside of science (e.g., engineers), may not learn about career opportunities in cancer prevention, or learn of them during mid-career, when transition to a new field would be more difficult. Thus, it is important to expose students to cancer prevention in their undergraduate and graduate studies through activities such as integrating cancer prevention into curricula, lectures available across universities, and applied training opportunities.

Many panel members thought it feasible and desirable for postdoctoral programs to recruit individuals from selected nontraditional disciplines (e.g., mathematicians, lawyers, etc.) and teach them cancer prevention principles; this would have the added benefit of fostering more diversity of perspectives. The following specific disciplines (in no priority order) were identified as needing more recruitment efforts to encourage them to become fellows in cancer prevention programs:

  • Medicine (e.g., primary care physicians and oncologists)

  • Nursing and allied health professions

  • Health services

  • Engineering (e.g., systems or chemical engineers)

  • Mathematics (including statistics)

  • Computer science (e.g., simulation modeling)

  • Law

  • Political science/public policy

  • Others (e.g., economics, toxicology, etc.)

Several specific strategies were suggested by panelists to help gain the interest of individuals from underrepresented disciplines and potentially recruiting them into fellowships; these are summarized in Table 1.

View this table:
  • View inline
  • View popup
Table 1.

Suggested strategies for recruiting people from a variety of disciplines, enhancing curricula, and improving career preparation for postdoctoral cancer prevention fellowship programs

Curriculum

Cancer prevention researchers come from different disciplines and pursue divergent academic and nonacademic career paths. Acknowledging these differences, panelists discussed core expectations for cancer prevention scientific knowledge and research skills for trainees regardless of discipline, recognizing that the ultimate goal is reducing population-level cancer incidence and mortality. With this in mind, four core science-related recommendations emerged, each with curriculum implications.

First, cancer prevention fellowship programs should strive to ensure that fellows understand the basic biology of cancer and how interventions can interrupt biologic processes (12, 13). Second, programs should provide essential epidemiologic and biostatistical training to promote in-depth knowledge of study designs, biases, and probability. Epidemiology and biostatistics were emphasized because they form the basis for providing, and interpreting, evidence that can lead to clinical- and population-based recommendations (14, 15).

Third, programs should provide behavioral science instruction so that cancer prevention researchers can better understand the theoretical and evidenced-based approaches to overcome barriers to behavior change (16). Finally, programs should provide training in effective knowledge synthesis and translation (17). This includes identifying, critically assessing, and summarizing the scientific literature on a cancer prevention topic, and being able to translate and communicate syntheses to scientific and lay audiences for purposes such as patient-provider communication or guideline or policy development. Specific strategies to assist fellows with these recommendations are listed in Table 1.

Panelists were aware of the National Postdoctoral Association (NPA) core competencies (discipline-specific conceptual knowledge, research skill development, communication skills, professionalism, leadership and management skills, and responsible conduct of research; ref. 18). They agreed that NPA competencies in areas besides scientific training were critical aspects of postdoctoral cancer prevention training because they are essential for scientists to function more effectively in the roles they may assume throughout their careers. Specific skills training mentioned by panelists for postdoctoral cancer prevention fellows were:

  • Leadership

  • Writing

  • Oral presentations

  • Media relations

  • Management

  • Human relations (including working as part of a team)

  • Budgeting

  • Negotiation

Career Preparation

The final topic considered was outplacement or career opportunities for fellows post-training. The two broad areas discussed were: (i) career options besides those in academic institutions; and (ii) academic career-specific issues, including the relative value of multidisciplinary training. Attendees acknowledged that most scientists with doctoral degrees, or who complete postdoctoral fellowships, will not become tenure-track researchers in academic settings. This is not unique to cancer prevention but extends broadly to the biomedical sciences (19). Many potential career options are available to fellows, such as basic research in private industry, government service, consulting, and working for nonprofit organizations. Most cancer prevention training programs, however, focus on preparing individuals for academic positions. Training program leaders need to recognize the diversity of employment options available and do more to help fellows identify, and prepare for, a variety of career paths.

Regarding academic careers, some panelists reiterated that the multidisciplinary nature of cancer prevention research was considered both a strength and a concern. For example, scientists with multidisciplinary training are not always required or desired for academic positions depending on the goals of the department—multidisciplinary research requires a team-based approach that some institutions may not promote or support. Other well-recognized concerns included traditional means of recognition, promotion, and tenure of scientists who predominantly engage in team-based research (5, 20). The means of securing recognition, promotion, and tenure in academic institutions has traditionally reinforced individual achievement and highly focused (e.g., more narrow) research topics, rather than applied team science. Moreover, the provision of multidisciplinary training may be more difficult if funding relies on mechanisms that tend to be hosted by a single department or laboratory. Panelists were optimistic, however, that multidisciplinary training should be valued at all levels and different career sectors, and believed cancer prevention research will continue to need contributions from different disciplines and rely upon team-based approaches. Specific strategies to improve fellows' career preparation are listed in Table 1.

Conclusion

Preventing cancer remains a critical goal in the United States and worldwide (21–23). Postdoctoral cancer prevention fellowships can play key roles in training scientists, clinicians, and others in the conduct of high-quality research, and ultimately to develop and implement effective approaches to prevent or control cancer. For cancer prevention, as for other scientific areas, it is important to periodically revisit the focus, curriculum, and career outcomes of training programs given the new and emerging areas of research, technology, methods, systems, and practice.

The major topics and strategies addressed by experts at the April 2013 meeting can help form the basis for cancer prevention training programs to consider modifications or new directions, and keep them updated with the changing scientific and employment climate for doctoral degree recipients and postdoctoral fellows. The suggestions discussed at this meeting are a valuable first step; implementing them will require concerted efforts by individuals and organizations at many levels.

Disclaimer

The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institutes of Health or the Centers for Disease Control and Prevention.

Acknowledgments

The authors thank Ming Lei of the NCI for his assistance.

Footnotes

  • ↵* R25 or T32 institutional grants.

  • Received November 18, 2013.
  • Accepted December 5, 2013.
  • ©2014 American Association for Cancer Research.

References

  1. 1.↵
    1. Weed DL,
    2. Greenwald P,
    3. Cullen JW
    . The future of cancer prevention and control. Semin Oncol 1990;17:504–09.
    OpenUrlPubMed
  2. 2.↵
    1. Bode AM,
    2. Dong Z
    . Cancer prevention—then and now. Nat Rev Cancer 2009;9:508–16.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Gaglio B,
    2. Shoup JA,
    3. Glasgow RE
    . The RE-AIM framework: a systematic review of use over time. Am J Public Health [Internet] 2013 Jun [cited 2013 Dec 12];103:[about 9 p.]. Available from: http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301299?url_ver=Z39.88--2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.
  4. 4.↵
    1. Stirman SW,
    2. Kimberly J,
    3. Cook N,
    4. Calloway A,
    5. Castro F,
    6. Charns M
    .The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research. Implement Sci [Internet]. 2012 Mar [cited 2013 Dec 12];7:[about 19 p.]. Available from: http://www.implementationscience.com/content/7/1/17.
    OpenUrl
  5. 5.↵
    1. Stokols D,
    2. Hall KA,
    3. Taylor BK,
    4. Moser RP
    . The science of team science: overview of the field and introduction to the supplement. Am J Prev Med 2008;35:S77–89.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Rimer BK,
    2. Abrams DB
    . Present and future horizons for transdisciplinary research. Am J Prev Med 2012;42:200–01.
    OpenUrlPubMed
  7. 7.↵
    1. Mabry PL,
    2. Olster DH,
    3. Morgan GD,
    4. Abrams DB
    . Interdisciplinarity and systems science to improve population health: a view from the NIH Office of Behavioral and Social Sciences Research. Am J Prev Med 2008;35:S211–24.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Luke DA,
    2. Stamatakis KA
    . Systems science methods in public health: dynamics, networks, and agents. Annu Rev Public Health 2012;33:357–76.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Collins LM,
    2. Murphy SA,
    3. Strecher V
    . The multiphase optimization strategy (MOST) and the sequential multiple assignment randomization trail (SMART): new methods for more potent eHealth interventions. Am J Prev Med 2007;32:S112–18.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Riley WT,
    2. Glasgow RE,
    3. Etheredge L,
    4. Abernethy AP
    . Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clin Transl Med 2013;2:10.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Chang S,
    2. Cameron C
    . Addressing the future burden of cancer and its impact on the oncology workforce: where is cancer prevention and control? J Canc Educ 2012;27:S118–27.
    OpenUrl
  12. 12.↵
    1. Hanrahan D,
    2. Weinberg RA
    . Hallmarks of cancer: the next generation. Cell 2011;144:646–74.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Umar A,
    2. Dunn BK,
    3. Greenwald P
    . Future directions in cancer prevention. Nat Rev Cancer 2012;12:835–48.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Sterman JD
    . Learning from evidence in a complex world. Am J Public Health 2006;96:505–14.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Brownson RC,
    2. Petitti DB
    . Applied epidemiology. 2nd ed. New York: Oxford; 2007.
  16. 16.↵
    1. Glanz K,
    2. Rimer BK,
    3. Viswanath K
    . Health behavior and health education: theory, research, and practice. 4th ed. Hoboken, NJ: John Wiley & Sons; 2008.
  17. 17.↵
    1. Graham IA
    . Knowledge synthesis and the Canadian Institutes of Health Research. Syst Rev [Internet]. 2012 Feb [cited 2013 Dec 13];1:[about 2 p.]. Available from: http://www.systematicreviewsjournal.com/content/1/1/6.
    OpenUrl
  18. 18.↵
    NPA Core Competencies Committee (2007–2009). The NPA postdoctoral core competencies toolkit [Internet]. Washington, DC: National Postdoctoral Association; 2009 [cited 2013 Jun 6]. Available from: http://www.nationalpostdoc.org/competencies.
  19. 19.↵
    National Institutes of Health Advisory Committee to the Director Biomedical Workforce Working Group. Biomedical research workforce working group report [Internet]. Bethesda, MD: NIH; 2012 [cited 2013 Jun 6]. Available from: http://acd.od.nih.gov/Biomedical_research_wgreport.pdf.
  20. 20.↵
    1. Zucker D
    . Developing your career in an era of team science. J Invest Sci 2012;60:779–84.
    OpenUrl
  21. 21.↵
    1. Boyle P,
    2. Levin B
    , editors. World cancer report 2008 [Internet]. Lyon, France: International Agency for Research on Cancer; 2008 [cited 2013 Dec 13]. Available from: http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/.
  22. 22.↵
    1. Colditz GA,
    2. Wolin KY,
    3. Gehlert S
    . Applying what we know to accelerate cancer prevention. Sci Transl Med [Internet]. 2012 Mar [cited 2013 Dec 13];4:[about 9 p.]. Available from: http://stm.sciencemag.org/content/4/127/127rv4.full.
    OpenUrl
  23. 23.↵
    1. Horton R
    . Non-communicable diseases: 2015–2025. Lancet 2013;381:509–10.
    OpenUrlPubMed
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (4)
April 2014
Volume 23, Issue 4
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts
David E. Nelson, Jessica Faupel-Badger, Siobhan Phillips, Britni Belcher, Shine Chang, David B. Abrams, Barnett S. Kramer, Mary C. White, Michael O'Malley, Arti P. Varanasi, Carol J. Fabian, Jonathan S. Wiest, Graham A. Colditz, Kara Hall, Peter G. Shields and Jeffrey N. Weitzel
Cancer Epidemiol Biomarkers Prev April 1 2014 (23) (4) 679-683; DOI: 10.1158/1055-9965.EPI-13-1209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of Experts
David E. Nelson, Jessica Faupel-Badger, Siobhan Phillips, Britni Belcher, Shine Chang, David B. Abrams, Barnett S. Kramer, Mary C. White, Michael O'Malley, Arti P. Varanasi, Carol J. Fabian, Jonathan S. Wiest, Graham A. Colditz, Kara Hall, Peter G. Shields and Jeffrey N. Weitzel
Cancer Epidemiol Biomarkers Prev April 1 2014 (23) (4) 679-683; DOI: 10.1158/1055-9965.EPI-13-1209
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Future Research Needs
    • Broadening and Expanding Disciplines Involved in Cancer Prevention Research
    • Curriculum
    • Career Preparation
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Implementation Science in Global Tobacco Control
  • Why Aren't Sexual Orientation/Gender Identity Being Measured?
  • U.S. Dietary Guidelines and Cancer Prevention
Show more ASPO Report
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement